Preclinical evaluation of 4‐[3,5‐bis(2‐chlorobenzylidene)‐4‐oxo‐piperidine‐1‐yl]‐4‐oxo‐2‐butenoic acid, in a mouse model of lung cancer xenograft
Vivek R. Yadav(National Institute of Pharmaceutical Education and Research), Vibhudutta Awasthi(University of Oklahoma Health Sciences Center)
Cited by 20
Related Papers
Pharmacologic Suppression of Inflammation by a Diphenyldifluoroketone, EF24, in a Rat Model of Fixed-Volume Hemorrhage Improves Survival
|Journal of Pharmacology and Experimental Therapeutics|2013|20